Delivery Order SPE2DB20D2104-SPE2DB23FT92S
Award Date
6/9/23
Potential Completion Date
6/12/23
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,301,694 units of the pharmaceutical product Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The Firm Fixed Price delivery order, valued at $1,361.16, has a completion date of December 18, 2023. This award is not designated with a set-aside requirement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,131.47, is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 100-count bottles. The contract has a period of performance through December 15, 2023 and uses a Firm Fixed Price pricing type. This contract award is not designated as a set-aside and...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,299.60 firm fixed price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-asides. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of triamterene-HCTZ 75-50 mg tablets. The contract, valued at $1,167.96, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,241.94 that was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets, a medication used for the treatment of hypertension. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,839.00 Firm Fixed Price Delivery Order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG Tablets (500 count) with a completion date of May 3, 2024. The contract was awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,952.91, is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,874.50 and a period of performance through June 28, 2024. The contract provides for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...